Please select a Capability in order to start your service request.
CareFusion Places in Top 10 for Overall Software Vendor RankingsFeb 19, 2014
SAN DIEGO, CA, Feb. 19, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader for Infection Control and Monitoring by KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations.
This marks the fourth time the MedMined Surveillance Advisor has received the highest rating in this category. Providers also ranked CareFusion ninth for Overall Software Vendor in its 2013 Best in KLAS: Software and Services report.
"MedMined Surveillance Advisor enables our customers to proactively and easily analyze their data to identify emerging infection trends, and help them provide education and clinical interventions to improve the patient care process," said Nivaldo Diaz, vice president of Technology Solutions for CareFusion. "We are proud that our customers have once again recognized CareFusion as providing a leading solution for Infection Control and Monitoring."
MedMined Surveillance Advisor provides automated infection surveillance proven to help hospitals identify and reduce health care associated infections (HAIs)—ultimately facilitating hospitals' efforts to save lives and reduce costs. The proprietary tool uses a proxy marker to identify potential HAIs, while algorithms automatically detect clinically meaningful patterns in complex data sets, similar to the data mining technology used by credit card companies to detect fraud. By placing the right information in the right hands at the right time, the infection prevention team is empowered to efficiently focus resources on emerging trends in HAIs and multiple-drug resistant organisms. This refined approach to surveillance allows for more time to be spent on clinical intervention and education.
MedMined Surveillance Advisor has been studied and published in numerous peer-reviewed publications, as well as financially peer-reviewed receiving the Healthcare Financial Management Association Peer Review designation.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.